Notice for thiotepa (Reach Pharmaceuticals Pty Ltd)
Active ingredients
thiotepa
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for Injection
Indication
Indicated in combination with other chemotherapy medicinal products as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT)
Therapeutic area
Oncogoly